Exposure to short day lengths for 9 weeks renders the hypothalamic-pituitary axis of the castrate hamster extremely responsive to the negative feedback effect of exogenous testosterone. The systemic and/or local conversion of testosterone to 5α-dihydrotestosterone (5α-DHT) or 17β-estradiol (E2) is considered to be an important step in its action on target tissues. The present study was designed to determine if the photoperiod can induce changes in the sensitivity of the hypothalamic-pituitary axis to the inhibitory effects of 5α-DHT or E2. 5α-DHT-filled Silastic capsules that were 2, 4, or 8 mm long greatly reduced serum LH and FSH levels in castrates that were exposed to a nonstimulatory LD 8:16 light cycle, but not in animals exposed to a stimulatory LD 14:10 light cycle. E2 capsules that were 1, 2, 4, or 8 mm long greatly reduced serum LH and FSH levels in castrates exposed to LD 8:16, but not in animals exposed to LD 14:10. Serum gonadotropin levels were reduced in all of the animals receiving the larger 5α-DHT (20 or 50 mm long) or E2 (20 mm long) capsules, irrespective of photoperiod. Thus, the photoperiod can alter the sensitivity of the gonadotropin control center to the negative feedback effect of both the 5α-reduced derivative of testosterone, 5α-DHT, and the aromatized metabolite of testosterone, E2. These results suggest that testicular secretions besides testosterone and/or extratesticular conversion of testosterone to its metabolites may be involved in the photoperiodic inhibition of the hamster reproductive system.

Keywords:
Hamster, Photoperiod, LH, FSH, 5α-Dihydrotestosterone, 17β-Estradiol
This content is only available via PDF.
© 1980 S. Karger AG, Basel
1980
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.